• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PFIZER CONSUMER HEALTH CARE THERMACARE NECK, SHOULDER & WRIST; DISPOSABLE PACK, HOT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PFIZER CONSUMER HEALTH CARE THERMACARE NECK, SHOULDER & WRIST; DISPOSABLE PACK, HOT Back to Search Results
Lot Number J68754
Device Problems Break (1069); Leak/Splash (1354)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
Investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: (b)(6) 2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.
 
Event Description
Event verbatim [preferred term] black spots on a heatwrap cells [device leakage] ,.Case narrative:this is a spontaneous report from a contactable pharmacist via product quality complaints.A patient of unspecified age and gender started to receive thermacare heatwrap (thermacare neck, shoulder & wrist), device lot number j68754, expiration date nov2017, date of manufacture 11dec2014, from an unspecified date for an unspecified indication.The patient's medical history and concomitant medications were not reported.The pharmacy reported black spots on a heatwrap cells on an unspecified date.The action taken with thermacare heatwrap was unknown.The outcome of the event was unknown.Product investigation results were received and were as follows: investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: (b)(6) 2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.Follow-up attempts not needed.No further information expected.Company clinical evaluation comment the event "black spots on a heatwrap cells " (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device., comment: the event "black spots on a heatwrap cells " (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device.
 
Event Description
Event verbatim [preferred term] black spots on a heatwrap cells [device leakage] ,.Case narrative:this is a spontaneous report from a contactable pharmacist via product quality complaints.A patient of unspecified age and gender started to receive thermacare heatwrap (thermacare neck, shoulder & wrist), device lot number j68754, expiration date nov2017, date of manufacture 11dec2014, from an unspecified date for an unspecified indication.The patient's medical history and concomitant medications were not reported.The pharmacy reported black spots on a heatwrap cells on an unspecified date.The action taken with thermacare heatwrap was unknown.The outcome of the event was unknown.Product investigation results were received and were as follows: investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: 24mar2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.Additional information has been requested and will be provided as it becomes available.Follow-up (24dec2019): this follow-up is being submitted to notify that an investigation of the device is ongoing.Company clinical evaluation comment the event "black spots on a heatwrap cells " (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device., comment: the event "black spots on a heatwrap cells " (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device.
 
Manufacturer Narrative
Investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: (b)(6) 2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.
 
Event Description
Event verbatim [preferred term] black spots on a heatwrap cells [device leakage] ,.Case narrative:this is a spontaneous report from a contactable pharmacist via product quality complaints regarding thermacare heatwrap (thermacare neck, shoulder & wrist), device lot number j68754, expiration date nov2017, date of manufacture 11dec2014.The pharmacy reported black spots on a heatwrap cells.The action taken with thermacare heatwrap was unknown.The outcome of the event was unknown.Product investigation results were received and were as follows: investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: 24mar2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.Follow-up (24dec2019): this follow-up is being submitted to notify that an investigation of the device is ongoing.Follow-up (19feb2020): this follow-up report is being submitted as a final reportable mdr., comment: the event "black spots on a heatwrap cells" (device leakage) was assessed as non-serious.No other adverse event was associated with the use of the device.This is a single potential device malfunction has a theoretical risk to cause skin burn.The event was assessed as associated with the use of the device.Company conducted an investigation, and the most probable root cause for this event was classified, capa was implemented, and no further action is recommended.
 
Manufacturer Narrative
Investigation summary: complaint confirmed: yes.Process related: yes.Capa in place: yes.Capa reference: commitment pr# modify the logic of the brine system to shutdown the line when the dosing brine arm proximity switch is damage.Data of capa implementation: 24mar2015.The most probable root cause of this incident is classified as equipment/equipment design.Evaluation of the return sample 03shows the wrap was not dosed with brine solution; therefore would not heat up.No quality issues were identified upon this review of batch records, release testing data or, inspection of retained samples.Retained samples met the product description and the product is in date.Our manufacturing operations employ quality control procedures which include in process testing, thermal testing and visual inspection, to ensure the quality of the product being packaged.The root cause of the wraps not being dosed with brine solution was equipment: the logic was not programmed to detect if the proximity switch at the brine dosing arm is detecting the motion of the arm when the production line is running.This allowed the production line continue to run without incurring a fault even though the brine pumps were not being driven.Therefore, no brine was being injected into the cells producing products with lower weights that was detected at the check weigher and diverted from the packaging line.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERMACARE NECK, SHOULDER & WRIST
Type of Device
DISPOSABLE PACK, HOT
Manufacturer (Section D)
PFIZER CONSUMER HEALTH CARE
1231 wyandotte drive
albany GA 31705
MDR Report Key9263339
MDR Text Key220272856
Report Number1066015-2019-00435
Device Sequence Number1
Product Code IMD
Combination Product (y/n)N
PMA/PMN Number
K953442
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup
Report Date 02/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/31/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/01/2017
Device Lot NumberJ68754
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/10/2017
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-